RepliCel Life Sciences Inc (OTCQB:REPCF)

0.346
Delayed Data
As of 12:21pm ET
 +0.006 / +1.76%
Today’s Change
0.26
Today|||52-Week Range
0.64
+6.79%
Year-to-Date
SECTOR
Non-Energy Minerals
INDUSTRY
Precious Metals
MARKET CAP
$18.7M

Company Description

RepliCel Life Sciences, Inc. is regenerative medicine company. It focuses on developing autologous cell therapies that address conditions linked to a deficit of healthy cells required for normal healing and function. The diseases currently being addressed are chronic tendinosis, skin aging, and androgenetic alopecia. RepliCel Life Sciences was founded on April 24, 1967 and is headquartered in Vancouver, Canada.

Contact Information

RepliCel Life Sciences, Inc.
401 West Georgia Street
Vancouver British Columbia V6B 5A1
P:(604) 248-8730
Investor Relations:
(604) 248-8693

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

David M. HallPresident, Chief Executive Officer & Director
Thomas Albert KordybackChief Financial Officer
Darrell PanichVice President-Clinical Affairs
Kevin McElweeChief Scientific Officer
Rolf HoffmannDirector & Chief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account